img

Global Pharmacovigilance (PV) Outsourcing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmacovigilance (PV) Outsourcing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Pharmacovigilance (PV) Outsourcing market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Contract Research Organizations (CROs) accounting for % of the Pharmacovigilance (PV) Outsourcing global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Premarketing Clinical Trial segment is altered to an % CAGR throughout this forecast period.
The global key companies of Pharmacovigilance (PV) Outsourcing include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Pharmacovigilance (PV) Outsourcing market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Pharmacovigilance (PV) Outsourcing landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Pharmacovigilance (PV) Outsourcing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Pharmacovigilance (PV) Outsourcing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Pharmacovigilance (PV) Outsourcing market. Readers of the report can become informed about current and future trends of the global Pharmacovigilance (PV) Outsourcing market and how they will impact market growth during the forecast period.



By Company


Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Segment by Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)

Segment by Application


Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Pharmacovigilance (PV) Outsourcing in global and regional level.
Chapter 3Detailed analysis of Pharmacovigilance (PV) Outsourcing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance (PV) Outsourcing revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Contract Research Organizations (CROs)
1.2.3 Business Process Outsourcing (BPOs)
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Pharmacovigilance (PV) Outsourcing Market Size (2018-2034)
2.2 Pharmacovigilance (PV) Outsourcing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2018-2024)
2.4 Global Pharmacovigilance (PV) Outsourcing Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Pharmacovigilance (PV) Outsourcing Countries Ranking by Market Size
3 Pharmacovigilance (PV) Outsourcing Competitive by Company
3.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Players
3.1.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2018-2024)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2018-2024)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2022
3.5 Global Key Players of Pharmacovigilance (PV) Outsourcing Head office and Area Served
3.6 Global Key Players of Pharmacovigilance (PV) Outsourcing, Product and Application
3.7 Global Key Players of Pharmacovigilance (PV) Outsourcing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Revenue by Type (2018-2024)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Revenue by Type (2024-2034)
5 Global Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2018-2024)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024)
6.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2034)
6.3 North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2034)
6.4 North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024)
7.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2034)
7.3 Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2034)
7.4 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024)
8.2 Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2034)
8.3 Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2034)
8.4 Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024)
9.2 Latin America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2034)
9.3 Latin America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2034)
9.4 Latin America Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024)
10.2 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2034)
10.3 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2034)
10.4 Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Accenture
11.1.1 Accenture Company Details
11.1.2 Accenture Business Overview
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Products and Services
11.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.1.5 Accenture Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.1.6 Accenture Recent Development
11.2 C3i Solutions
11.2.1 C3i Solutions Company Details
11.2.2 C3i Solutions Business Overview
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Products and Services
11.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.2.5 C3i Solutions Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.2.6 C3i Solutions Recent Development
11.3 Clintec
11.3.1 Clintec Company Details
11.3.2 Clintec Business Overview
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Products and Services
11.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.3.5 Clintec Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.3.6 Clintec Recent Development
11.4 Covance
11.4.1 Covance Company Details
11.4.2 Covance Business Overview
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Products and Services
11.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.4.5 Covance Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.4.6 Covance Recent Development
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Details
11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Products and Services
11.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.5.5 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.5.6 Deloitte Touche Tohmatsu Limited Recent Development
11.6 ELC Group
11.6.1 ELC Group Company Details
11.6.2 ELC Group Business Overview
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Products and Services
11.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.6.5 ELC Group Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.6.6 ELC Group Recent Development
11.7 Ergomed
11.7.1 Ergomed Company Details
11.7.2 Ergomed Business Overview
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Products and Services
11.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.7.5 Ergomed Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.7.6 Ergomed Recent Development
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Details
11.8.2 iGATE Corporation Business Overview
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Products and Services
11.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.8.5 iGATE Corporation Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.8.6 iGATE Corporation Recent Development
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Details
11.9.2 iMED Global Corporation Business Overview
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Products and Services
11.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.9.5 iMED Global Corporation Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.9.6 iMED Global Corporation Recent Development
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Products and Services
11.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.10.5 IQVIA Pharmacovigilance (PV) Outsourcing SWOT Analysis
11.10.6 IQVIA Recent Development
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Details
11.11.2 MarksMan Healthcare Business Overview
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Products and Services
11.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.11.5 MarksMan Healthcare Recent Development
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Details
11.12.2 Medpace Holdings Business Overview
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Products and Services
11.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.12.5 Medpace Holdings Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Products and Services
11.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.13.5 Novartis Recent Development
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Details
11.14.2 Oracle Corporation Business Overview
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Products and Services
11.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.14.5 Oracle Corporation Recent Development
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Products and Services
11.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.15.5 Parexel Recent Development
11.16 PharmInvent
11.16.1 PharmInvent Company Details
11.16.2 PharmInvent Business Overview
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Products and Services
11.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.16.5 PharmInvent Recent Development
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Details
11.17.2 PrimeVigilance Business Overview
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Products and Services
11.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.17.5 PrimeVigilance Recent Development
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Details
11.18.2 Pure Drug Safety Business Overview
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Products and Services
11.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.18.5 Pure Drug Safety Recent Development
11.19 Sciformix
11.19.1 Sciformix Company Details
11.19.2 Sciformix Business Overview
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Products and Services
11.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.19.5 Sciformix Recent Development
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Details
11.20.2 SIRO Clinpharm Business Overview
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Products and Services
11.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.20.5 SIRO Clinpharm Recent Development
11.21 Symogen
11.21.1 Symogen Company Details
11.21.2 Symogen Business Overview
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Products and Services
11.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
11.21.5 Symogen Recent Development
12 Pharmacovigilance (PV) Outsourcing Market Dynamics
12.1 Pharmacovigilance (PV) Outsourcing Industry Trends
12.2 Pharmacovigilance (PV) Outsourcing Market Drivers
12.3 Pharmacovigilance (PV) Outsourcing Market Challenges
12.4 Pharmacovigilance (PV) Outsourcing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Contract Research Organizations (CROs)
Table 3. Key Players of Business Process Outsourcing (BPOs)
Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global Pharmacovigilance (PV) Outsourcing Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Pharmacovigilance (PV) Outsourcing Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global Pharmacovigilance (PV) Outsourcing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2018-2024)
Table 11. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2022)
Table 12. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of Pharmacovigilance (PV) Outsourcing, Headquarters and Area Served
Table 15. Global Key Players of Pharmacovigilance (PV) Outsourcing, Product and Application
Table 16. Global Key Players of Pharmacovigilance (PV) Outsourcing, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2024)
Table 20. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2024-2034)
Table 22. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2024)
Table 24. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2024-2034)
Table 26. North America Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America Pharmacovigilance (PV) Outsourcing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe Pharmacovigilance (PV) Outsourcing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific Pharmacovigilance (PV) Outsourcing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America Pharmacovigilance (PV) Outsourcing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America Pharmacovigilance (PV) Outsourcing Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2024-2034) & (US$ Million)
Table 66. Accenture Company Details
Table 67. Accenture Business Overview
Table 68. Accenture Pharmacovigilance (PV) Outsourcing Product and Services
Table 69. Accenture Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 70. Accenture Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 71. Accenture Recent Development
Table 72. C3i Solutions Company Details
Table 73. C3i Solutions Business Overview
Table 74. C3i Solutions Pharmacovigilance (PV) Outsourcing Product and Services
Table 75. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 76. C3i Solutions Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 77. C3i Solutions Recent Development
Table 78. Clintec Company Details
Table 79. Clintec Business Overview
Table 80. Clintec Pharmacovigilance (PV) Outsourcing Product and Services
Table 81. Clintec Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 82. Clintec Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 83. Clintec Recent Development
Table 84. Covance Company Details
Table 85. Covance Business Overview
Table 86. Covance Pharmacovigilance (PV) Outsourcing Product and Services
Table 87. Covance Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 88. Covance Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 89. Covance Recent Development
Table 90. Deloitte Touche Tohmatsu Limited Company Details
Table 91. Deloitte Touche Tohmatsu Limited Business Overview
Table 92. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product and Services
Table 93. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 94. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 95. Deloitte Touche Tohmatsu Limited Recent Development
Table 96. ELC Group Company Details
Table 97. ELC Group Business Overview
Table 98. ELC Group Pharmacovigilance (PV) Outsourcing Product and Services
Table 99. ELC Group Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 100. ELC Group Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 101. ELC Group Recent Development
Table 102. Ergomed Company Details
Table 103. Ergomed Business Overview
Table 104. Ergomed Pharmacovigilance (PV) Outsourcing Product and Services
Table 105. Ergomed Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 106. Ergomed Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 107. Ergomed Recent Development
Table 108. iGATE Corporation Company Details
Table 109. iGATE Corporation Business Overview
Table 110. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product and Services
Table 111. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 112. iGATE Corporation Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 113. iGATE Corporation Recent Development
Table 114. iMED Global Corporation Company Details
Table 115. iMED Global Corporation Business Overview
Table 116. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product and Services
Table 117. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 118. iMED Global Corporation Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 119. iMED Global Corporation Recent Development
Table 120. IQVIA Company Details
Table 121. IQVIA Business Overview
Table 122. IQVIA Pharmacovigilance (PV) Outsourcing Product and Services
Table 123. IQVIA Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 124. IQVIA Pharmacovigilance (PV) Outsourcing SWOT Analysis
Table 125. IQVIA Recent Development
Table 126. MarksMan Healthcare Company Details
Table 127. MarksMan Healthcare Business Overview
Table 128. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product and Services
Table 129. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 130. MarksMan Healthcare Recent Development
Table 131. Medpace Holdings Company Details
Table 132. Medpace Holdings Business Overview
Table 133. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product and Services
Table 134. Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 135. Medpace Holdings Recent Development
Table 136. Novartis Company Details
Table 137. Novartis Business Overview
Table 138. Novartis Pharmacovigilance (PV) Outsourcing Product and Services
Table 139. Novartis Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 140. Novartis Recent Development
Table 141. Oracle Corporation Company Details
Table 142. Oracle Corporation Business Overview
Table 143. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product and Services
Table 144. Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 145. Oracle Corporation Recent Development
Table 146. Parexel Company Details
Table 147. Parexel Business Overview
Table 148. Parexel Pharmacovigilance (PV) Outsourcing Product and Services
Table 149. Parexel Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 150. Parexel Recent Development
Table 151. PharmInvent Company Details
Table 152. PharmInvent Business Overview
Table 153. PharmInvent Pharmacovigilance (PV) Outsourcing Product and Services
Table 154. PharmInvent Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 155. PharmInvent Recent Development
Table 156. PrimeVigilance Company Details
Table 157. PrimeVigilance Business Overview
Table 158. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product and Services
Table 159. PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 160. PrimeVigilance Recent Development
Table 161. Pure Drug Safety Company Details
Table 162. Pure Drug Safety Business Overview
Table 163. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product and Services
Table 164. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 165. Pure Drug Safety Recent Development
Table 166. Sciformix Company Details
Table 167. Sciformix Business Overview
Table 168. Sciformix Pharmacovigilance (PV) Outsourcing Product and Services
Table 169. Sciformix Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 170. Sciformix Recent Development
Table 171. SIRO Clinpharm Company Details
Table 172. SIRO Clinpharm Business Overview
Table 173. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product and Services
Table 174. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 175. SIRO Clinpharm Recent Development
Table 176. Symogen Company Details
Table 177. Symogen Business Overview
Table 178. Symogen Pharmacovigilance (PV) Outsourcing Product and Services
Table 179. Symogen Pharmacovigilance (PV) Outsourcing Revenue in Pharmacovigilance (PV) Outsourcing Business (2018-2024) & (US$ Million)
Table 180. Symogen Recent Development
Table 181. Pharmacovigilance (PV) Outsourcing Market Trends
Table 182. Pharmacovigilance (PV) Outsourcing Market Drivers
Table 183. Pharmacovigilance (PV) Outsourcing Market Challenges
Table 184. Pharmacovigilance (PV) Outsourcing Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmacovigilance (PV) Outsourcing Product Picture
Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2022 VS 2034
Figure 4. Contract Research Organizations (CROs) Features
Figure 5. Business Process Outsourcing (BPOs) Features
Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2022 VS 2034
Figure 8. Premarketing Clinical Trial
Figure 9. Post-marketing Clinical Practice
Figure 10. Other
Figure 11. Pharmacovigilance (PV) Outsourcing Report Years Considered
Figure 12. Global Pharmacovigilance (PV) Outsourcing Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Size 2018-2034 (US$ Million)
Figure 14. Global Pharmacovigilance (PV) Outsourcing Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Pharmacovigilance (PV) Outsourcing Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Pharmacovigilance (PV) Outsourcing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2022
Figure 20. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2022
Figure 22. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company in 2022
Figure 23. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 24. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 25. North America Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2018-2034)
Figure 26. U.S. Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company in 2022
Figure 29. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 30. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 31. Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2018-2034)
Figure 32. Germany Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 33. France Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Pharmacovigilance (PV) Outsourcing Revenue Share by Region (2018-2034)
Figure 41. China Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 44. India Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 46. Taiwan Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 50. Philippines Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 51. Vietnam Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company in 2022
Figure 53. Latin America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 54. Latin America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 55. Latin America Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2018-2034)
Figure 56. Mexico Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2018-2034)
Figure 63. Turkey Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 65. U.A.E Pharmacovigilance (PV) Outsourcing Revenue (2018-2034) & (US$ Million)
Figure 66. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 67. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 68. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 69. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 70. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 71. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 72. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 73. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 74. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 75. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 76. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 77. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 78. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 79. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 80. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 81. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 82. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 83. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 84. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 85. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 86. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2018-2024)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed